Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
van der Kolk, Mike
de Vlas, Sake J.
and
Sauerwein, Robert W.
2006.
Reduction and enhancement of Plasmodium falciparum transmission by endemic human sera.
International Journal for Parasitology,
Vol. 36,
Issue. 10-11,
p.
1091.
RICHIE, T.
2006.
High road, low road? Choices and challenges on the pathway to a malaria vaccine.
Parasitology,
Vol. 133,
Issue. S2,
p.
S113.
Ramjanee, Souraya
Robertson, James S.
Franke-Fayard, Blandine
Sinha, Ria
Waters, Andrew P.
Janse, Chris J.
Wu, Yimin
Blagborough, Andrew M.
Saul, Allan
and
Sinden, Robert E.
2007.
The use of transgenic Plasmodium berghei expressing the Plasmodium vivax antigen P25 to determine the transmission-blocking activity of sera from malaria vaccine trials.
Vaccine,
Vol. 25,
Issue. 5,
p.
886.
BOUSEMA, J. T.
DRAKELEY, C. J.
KIHONDA, J.
HENDRIKS, J. C. M.
AKIM, N. I. J.
ROEFFEN, W.
and
SAUERWEIN, R. W.
2007.
A longitudinal study of immune responses to Plasmodium falciparum sexual stage antigens in Tanzanian adults.
Parasite Immunology,
Vol. 29,
Issue. 6,
p.
309.
SAUL, A.
HENSMANN, M.
SATTABONGKOT, J.
COLLINS, W. E.
BARNWELL, J. W.
LANGERMANS, J. A. M.
WU, Y.
LONG, C. A.
DUBOVSKY, F.
and
THOMAS, A. W.
2007.
Immunogenicity in rhesus of the Plasmodium vivax mosquito stage antigen Pvs25H with Alhydrogel and Montanide ISA 720.
Parasite Immunology,
Vol. 29,
Issue. 10,
p.
525.
Miura, Kazutoyo
Keister, David B
Muratova, Olga V
Sattabongkot, Jetsumon
Long, Carole A
and
Saul, Allan
2007.
Transmission-blocking activity induced by malaria vaccine candidates Pfs25/Pvs25 is a direct and predictable function of antibody titer.
Malaria Journal,
Vol. 6,
Issue. 1,
GOUAGNA, L. C.
VAN DER KOLK, M.
ROEFFEN, W.
VERHAVE, J.-P.
ELING, W.
SAUERWEIN, R.
and
BOUDIN, C.
2007.
Role of heat-labile serum factor or host complement in the inhibition ofPlasmodium falciparumsporogonic stages inAnopheles stephensiby gametocyte carriers' serological factors.
Parasitology,
Vol. 134,
Issue. 10,
p.
1315.
Outchkourov, Nikolay S.
Roeffen, Will
Kaan, Anita
Jansen, Josephine
Luty, Adrian
Schuiffel, Danielle
van Gemert, Geert Jan
van de Vegte-Bolmer, Marga
Sauerwein, Robert W.
and
Stunnenberg, Hendrik G.
2008.
Correctly folded Pfs48/45 protein of
Plasmodium falciparum
elicits malaria transmission-blocking immunity in mice
.
Proceedings of the National Academy of Sciences,
Vol. 105,
Issue. 11,
p.
4301.
Saeed, Maha
Roeffen, Will
Alexander, Neal
Drakeley, Christopher J.
Targett, Geoffrey A. T.
Sutherland, Colin J.
and
Rodrigues, Mauricio Martins
2008.
Plasmodium falciparum Antigens on the Surface of the Gametocyte-Infected Erythrocyte.
PLoS ONE,
Vol. 3,
Issue. 5,
p.
e2280.
Sutherland, Colin J.
2009.
Surface antigens of Plasmodium falciparum gametocytes—A new class of transmission-blocking vaccine targets?.
Molecular and Biochemical Parasitology,
Vol. 166,
Issue. 2,
p.
93.
Moorthy, Vasee S
and
Kieny, Marie Paule
2010.
Reducing empiricism in malaria vaccine design.
The Lancet Infectious Diseases,
Vol. 10,
Issue. 3,
p.
204.
Kone, Aminatou
Vegte-Bolmer, Marga van de
Siebelink-Stoter, Rianne
Gemert, Geert-Jan van
Dara, Antoine
Niangaly, Hamidou
Luty, Adrian
Doumbo, Ogobara K.
Sauerwein, Robert
and
Djimde, Abdoulaye A.
2010.
Sulfadoxine–pyrimethamine impairs Plasmodium falciparum gametocyte infectivity and Anopheles mosquito survival.
International Journal for Parasitology,
Vol. 40,
Issue. 10,
p.
1221.
Cheru, Lediya
Wu, Yimin
Diouf, Ababacar
Moretz, Samuel E.
Muratova, Olga V.
Song, Guanhong
Fay, Michael P.
Miller, Louis H.
Long, Carole A.
and
Miura, Kazutoyo
2010.
The IC50 of anti-Pfs25 antibody in membrane-feeding assay varies among species.
Vaccine,
Vol. 28,
Issue. 27,
p.
4423.
Smith, Thomas A.
Chitnis, Nakul
Briët, Olivier J.T.
and
Tanner, Marcel
2011.
Uses of mosquito-stage transmission-blocking vaccines against Plasmodium falciparum.
Trends in Parasitology,
Vol. 27,
Issue. 5,
p.
190.
Arévalo-Herrera, Myriam
Solarte, Yezid
Marin, Catherin
Santos, Mariana
Castellanos, Jenniffer
Beier, John C
and
Valencia, Sócrates Herrera
2011.
Malaria transmission blocking immunity and sexual stage vaccines for interrupting malaria transmission in Latin America.
Memórias do Instituto Oswaldo Cruz,
Vol. 106,
Issue. suppl 1,
p.
202.
Palacios, Ricardo
Jordán-Villegas, Alejandro
Echavarría, Juan Fernando
Richie, Thomas L.
Herrera, Sócrates
Solarte, Yezid
Epstein, Judith E.
Ramírez, Óscar
Vélez, Juan D.
Rocha, Leonardo
and
Arévalo-Herrera, Myriam
2011.
Consistent Safety and Infectivity in Sporozoite Challenge Model of Plasmodium vivax in Malaria-Naive Human Volunteers.
The American Journal of Tropical Medicine and Hygiene,
Vol. 84,
Issue. 2_Suppl,
p.
4.
Greenwood, B.M.
and
Targett, G.A.T.
2011.
Malaria vaccines and the new malaria agenda.
Clinical Microbiology and Infection,
Vol. 17,
Issue. 11,
p.
1600.
Farrance, Christine E.
Rhee, Amy
Jones, R. Mark
Musiychuk, Konstantin
Shamloul, Moneim
Sharma, Satish
Mett, Vadim
Chichester, Jessica A.
Streatfield, Stephen J.
Roeffen, Will
van de Vegte-Bolmer, Marga
Sauerwein, Robert W.
Tsuboi, Takafumi
Muratova, Olga V.
Wu, Yimin
and
Yusibov, Vidadi
2011.
A Plant-Produced Pfs230 Vaccine Candidate Blocks Transmission of Plasmodium falciparum.
Clinical and Vaccine Immunology,
Vol. 18,
Issue. 8,
p.
1351.
Bousema, Teun
and
Drakeley, Chris
2011.
Epidemiology and Infectivity of Plasmodium falciparum and Plasmodium vivax Gametocytes in Relation to Malaria Control and Elimination.
Clinical Microbiology Reviews,
Vol. 24,
Issue. 2,
p.
377.
Bousema, Teun
Sutherland, Colin J.
Churcher, Thomas S.
Mulder, Bert
Gouagna, Louis C.
Riley, Eleanor M.
Targett, Geoffrey A.T.
and
Drakeley, Chris J.
2011.
Human immune responses that reduce the transmission of Plasmodium falciparum in African populations.
International Journal for Parasitology,
Vol. 41,
Issue. 3-4,
p.
293.